Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34 + cell recovery

References

• Civin C, Trischman T, Fackler M et al Summary of CD34 cluster workshop section. In: Knapp W, Dorken B, Gilks WR et al., eds. Leukocyte typing IV. Oxford: Oxford University Press, 1989: 818–25.
   Google Scholar
• Sutherland DR, Keating A. The CD34 antigen: structure, biology and potential clinical applications. 7 Hematother 1992;1:115–29.
   PubMedGoogle Scholar
• Broxmeyer HE, Douglas G, Hangoc G et al Human umbil-ical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828–32.
   PubMed Web of Science ®Google Scholar
• Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitution in a patient with fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl 7 Med 1989;321:1179–8.
   Google Scholar
• Rubenstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl 7 Med 1998;339:1556–77 .
   Google Scholar
• Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665–78.
   PubMed Web of Science ®Google Scholar
• Drygalski A, Xu G, Constantinescu D et al. The frequency and proliferative potential of megakaryocytic colony-form-ing cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation. Bone Marrow Transplant 2000;25:1029–34.
   Google Scholar
• Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord blood transplantation from related and unrelated donor. N Engl .7 Med 1997;337:373–81.
   PubMed Web of Science ®Google Scholar
• Migliaccio AR, Adamson JW, Stevens CE et al Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better pre-dictor than leukocyte cell quantity. Blood 2000;96:2717–22.
   PubMed Web of Science ®Google Scholar
• Andrews RG, Singer JW, Bernstein ID. Human hematopoi-etic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells. yExp Med 1990;172: 355–8.
   Google Scholar
• Murray L, Chen B, Galy A et al. Enrichment of human hematopoietic stem cell activity in the CD34+ Thyl ± Lin—subpopulation from mobilized peripheral blood. Blood 1985;85:368–78.
   Google Scholar
• Sutherland DR, Yeo EL, Stewart AK et al Identification of CD34+ subsets following glycoprotease selection: engraft-ment of CD34±/Thy-1+/Lin— stem cells in fetal sheep. Exp Hematol 1996;24:795–806.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Wang JCY, Kapp U et al Purification of primitivehuman hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997;94:5320–5.
   PubMed Web of Science ®Google Scholar
• Yin AH, Miraglia S, Zanjani ED et al AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002–12.
   PubMed Web of Science ®Google Scholar
• Negrin RS, Atkinson K, Leemhuis T et al. Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 2000;6:262–71.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Keating A, Nayar R et al Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 1994;22:1003–10.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Anderson L, Keeney M et al. The IS HAGE guidelines for CD34+ cell determination by flow cytometry. yHematother 1996;3:213–26.
   Google Scholar
• Keeney M, Chin-Yee I, Weir K et al. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998;34:61–70.
   PubMedGoogle Scholar
• Gratama JW, Keeney M, Sutherland DR. Enumeration of CD34+ hematopoietic stem and progenitor cells. Current protocols. Cytometty 1999; Unit 6.4.1–6.4.22.
   Google Scholar
• Fraser JK, Cairo MS, Wagner EL et al. Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. y Hematother 1998;7:521–61.
   PubMedGoogle Scholar
• Rubinstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119–22.
   PubMed Web of Science ®Google Scholar
• Armitage S, Warwick R, Fehily D et al. Cord blood banking inLondon: the first 1000 collections. Bone MarrowTransplant 1999;24:139–45.
   Google Scholar
• Broxmeyer HE, Cooper S. High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopre-served for 10 years. Clin Exp Immunol 1997;107(Suppl 1):45–53.
   Google Scholar
• Denning-Kendall P, Donaldson C, Nicol A et al. Optimal processing of human umbilical cord blood for clinical bank-ing. Exp Hematol 1996;24:1399–401.
   Google Scholar
• Chin-Yee I, Anderson L, Keeney M, Sutherland DR et al. Quality assurance of stem cell enumeration by flow cytom-etry. Cytometry 1997;30:296–303.
   PubMedGoogle Scholar
• Isoyama K, Yamada K, Hirota Y et al Study of the collection and separation of umbilical cord blood in use in hematopoi-etic progenitor cell transplantation. Int y Hematol 1996;63:95–102.
   Google Scholar
• Campos L, Roubi N, Guyotat D. Definition of optimal con-ditions for the collection and cryopreservation of umbilical cord hematopoietic cells. Cryobiology 1995;32:511–515.
   Google Scholar
• Diaz MA, Alegre A, Benito A et al Peripheral blood progen-itor cell collection by large-volume leukapheresis in low-weight children. y Hematother 1998;7:63–8.
   PubMedGoogle Scholar
• Weaver CH, Potz J, Redmond J et al. Engraftment and out-comes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplant 1997;19: 1103–10.
   PubMed Web of Science ®Google Scholar